Tandem Diabetes Care (TNDM) sees Significant Insider Buying

Tuesday, February 13, 2018 10:15 PM ET

Tandem Diabetes Care (TNDM) sees Significant Insider Buying

In relation to the peer group over the last 90 days, insider buy/sell trading at Tandem Diabetes Care is above the 83-company peer group average. Medical Equipment, Supplies & Distribution peer group saw 81 buy/sell trades during this period for an average of 1.0 transactions per company. The number of shares per buy/sell trade for Tandem Diabetes Care insiders was also higher. Within the peer group there were 2,315,439 shares purchased and 1,350,374 shares sold with company insiders having bought 17,547 shares on average.

In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated data sourced to evaluate and write this story.

Today’s Insider Activity
* Kim D Blickenstaff, Director and Officer, bought 750,000 shares
* Christopher J Twomey, Director, bought 75,000 shares
* Douglas A Roeder, Director, bought 1,000,000 shares
* Dick Allen, Director, bought 60,000 shares
* Howard E Greene, Director, bought 50,000 shares

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.